# Acute Psychosis as the Initial Presentation of Systemic Lupus Erythematosus Complicated by Posterior Reversible Encephalopathy Syndrome With Hemorrhage: A Case Report

**Authors:** Anas E Ahmed, Bothinah M Al Zahib, Aisha R Al-Rashidi, Abdulnasir H Almassloom, Nawaf S Althobaiti

PMC · DOI: 10.7759/cureus.102238 · Cureus · 2026-01-24

## TL;DR

A young woman with no psychiatric history developed sudden psychosis due to an undiagnosed autoimmune disease and brain swelling, which improved with timely treatment.

## Contribution

This case highlights acute psychosis as a rare initial sign of systemic lupus erythematosus complicated by PRES with hemorrhage.

## Key findings

- Acute psychosis in a young patient was linked to undiagnosed systemic lupus erythematosus and PRES with hemorrhage.
- Timely neuroimaging and systemic evaluation led to diagnosis and successful treatment with immunosuppression and blood pressure control.
- The case underscores the importance of multidisciplinary care in managing complex neuropsychiatric autoimmune presentations.

## Abstract

Acute psychosis may rarely represent the initial presentation of an underlying systemic and potentially life-threatening medical disorder, posing significant diagnostic and management challenges.

We report the case of a young woman with no prior psychiatric history who presented with abrupt-onset psychosis and behavioral disturbance. Early neuroimaging revealed posterior-predominant vasogenic edema with associated intracerebral hemorrhage, consistent with posterior reversible encephalopathy syndrome (PRES). Further evaluation demonstrated hematological abnormalities, renal involvement, and positive autoimmune serology, leading to the diagnosis of previously unrecognized systemic lupus erythematosus (SLE) with neuropsychiatric involvement. The patient was managed with blood pressure control, immunosuppressive therapy, and supportive neurological and psychiatric care, resulting in marked clinical and radiological improvement. This case emphasizes the importance of maintaining a broad differential diagnosis when evaluating acute psychosis, particularly in young patients with atypical features or abnormal neurological findings. Early neuroimaging and comprehensive systemic workup were critical in identifying a reversible neurological syndrome secondary to an autoimmune disease, allowing timely intervention and a favorable outcome.

The report highlights PRES as an important and potentially reversible cause of acute neuropsychiatric symptoms in SLE and underscores the need for multidisciplinary collaboration to optimize diagnosis, treatment, and prognosis in such complex presentations.

## Linked entities

- **Diseases:** systemic lupus erythematosus (MONDO:0007915), posterior reversible encephalopathy syndrome (MONDO:0044033)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** infarction (MESH:D007238), renal abnormalities (MESH:D007674), Acute Psychosis (MESH:D011605), malar rash (MESH:C000721270), tenderness (MESH:D063806), neurological deterioration (MESH:D009422), PRES (MESH:D054038), cognitive dysfunction (MESH:D003072), anemia (MESH:D000740), hallucinations (MESH:D006212), hypertension (MESH:D006973), demyelination (MESH:D003711), neurological injury (MESH:D020196), cytopenias (MESH:D006402), death (MESH:D003643), delusions (MESH:D063726), intracerebral hemorrhage (MESH:D002543), agitation (MESH:D011595), infection (MESH:D007239), coagulopathy (MESH:D001778), neuropsychiatric (MESH:C000631768), thrombocytopenia (MESH:D013921), Psychosis (MESH:D011618), ischemic stroke (MESH:D002544), cerebrovascular disease (MESH:D002561), vascular injury (MESH:D057772), joint pains (MESH:D018771), renal involvement (MESH:C565423), vasogenic edema (MESH:D001929), rash (MESH:D005076), leukopenia (MESH:D007970), mood disorders (MESH:D019964), autoimmune (MESH:D001327), Hemorrhage (MESH:D006470), neurological disease (MESH:D020271), medical disorder (MESH:D000069279), neurological deficits (MESH:D009461), seizure (MESH:D012640), metabolic derangements (MESH:D008659), fever (MESH:D005334), proteinuria (MESH:D011507), Systemic Lupus (MESH:D008180), disorganized behavior (MESH:D012562), neurological conditions (MESH:D019636), vasculitis (MESH:D014657), headache (MESH:D006261), conditions (MESH:D020763), neuropsychiatric complications (MESH:D008107), Inflammatory (MESH:D007249), cerebral vasculitis (MESH:D020293), head trauma (MESH:D006259), systemic autoimmune disease (MESH:D020274), visual disturbances (MESH:D014786), hematuria (MESH:D006417), neuropsychiatric symptoms (MESH:D001523), insomnia (MESH:D007319), NPSLE (MESH:D020945), weakness (MESH:D018908), endothelial dysfunction (MESH:D014652), paranoid (MESH:D010259)
- **Chemicals:** vitamin B12 (MESH:D014805), creatinine (MESH:D003404), hydroxychloroquine (MESH:D006886), methylprednisolone (MESH:D008775), oxygen (MESH:D010100), ammonia (MESH:D000641)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930111/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12930111/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12930111/full.md

---
Source: https://tomesphere.com/paper/PMC12930111